R&D and Formulation Development

We do not just replicate standard molecules. Our development work is applied: enhancing drug safety, patient compliance and clinical efficacy under Indian conditions.

Research & formulation

Our R&D and Formulation Development strategy is the scientific foundation of our Mumbai headquarters — turning complex chemical compounds into superspeciality treatments and effective consumer healthcare products.

Base: Mumbai HQ
Core pillars: 3
Stages to market: 5
Stability zone: IVB

What we work on

Five areas of focus

01
Optimised bioavailability of critical molecules at practical dosages.
02
Advanced drug delivery systems — sustained-release, extended-release and enteric-coated forms.
03
Targeted topical systems for musculoskeletal pain.
04
Formulation stability under Indian storage conditions (Zone IVB).
05
Structural nutrition design for clinical-grade nutraceuticals.

Core pillars

Three disciplines behind every product

F&D

Advanced formulation development

Optimising the physical and chemical design of a drug so it performs reliably inside the human body.

Optimised bioavailabilityDrug matrices modified to improve absorption of critical molecules, so patients get therapeutic results at optimised dosages.
Advanced drug delivery systemsSustained-release, extended-release and enteric-coated forms: steadier release, fewer doses, less gastric discomfort.
Targeted topical systemsA multi-action lipid matrix combining diclofenac with linseed oil and capsaicin, for rapid skin penetration without a greasy residue.

AMD

Analytical method development

Before any formulation goes into commercial production, it must pass analytical screening.

Stability testingForced degradation studies show how our ethical and OTC products behave under heat, light and humidity.
Impurity profilingHigh-performance liquid chromatography (HPLC) maps and eliminates microscopic impurities.

Nutraceuticals

Structural nutrition design

Clinical nutrition treated with the same rigour as prescription drugs.

Synergistic formulationsIn Argi-C, the metabolic pathways of L-arginine and L-citrulline are mapped to support nitric oxide production, with a collagen matrix for tissue repair.
Chelation and bio-absorptionOrganic mineral chelates — boron proteinate in Argi-C, chromium and selenium complexes in Trace-M — support intestinal absorption.

Delivery formats

What our formulation work ships as

Formulation development decides the form a medicine reaches the patient in — an injectable, a capsule, a tablet or a topical system. This is our published range, counted by format.

Live from our product catalogue · 17 published products

Format	Products	Share
Injectables	11	65%
Capsules	4	24%
Tablets	2	12%

The path to market

From lab scale to commercial success

1
Literature and clinical gap analysis

Unmet medical needs identified across oncology, neurology, cardiology and our other divisions.
2
Pre-formulation studies

API characterisation and excipient compatibility analysed before a formula is attempted.
3
Lab-scale batch trial

The first prototype formula is developed in a controlled lab environment.
4
Pilot scale-up and stability

Formula stability tested against extreme Indian weather conditions before scale-up.
5
Commercial tech transfer

The validated master formula moves to WHO-GMP certified manufacturing plants.

For our partners

Why our R&D strength matters

Therapeutic edge

Partners get specialised, hard-to-replicate combinations that stand out to consulting doctors.

Regulatory readiness

Comprehensive scientific data portfolios mean approvals are supported by a complete dossier, keeping launches moving.

Longer shelf life

Stability engineering helps products hold potency through their commercial life, reducing expiry returns.

Where to next

Quality assurance The tests every batch faces before release. Read more Regulatory compliance The law we operate under, and how we keep to it. Read more Science & Quality overview How a product is developed, made, tested and monitored. Read more